ADMA BIOLOGICS INC (ADMA) Stock Fundamental Analysis
USA - NASDAQ:ADMA - US0008991046 - Common Stock
15.395 USD
+0.09 (+0.62%)
ADMA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 540 industry peers in the Biotechnology industry. ADMA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ADMA is evaluated to be cheap and growing strongly. This does not happen too often! This makes ADMA very considerable for value and growth investing!
1. Profitability
1.1 Basic Checks
In the past year ADMA was profitable.
ADMA had a positive operating cash flow in the past year.
In the past 5 years ADMA reported 4 times negative net income.
In multiple years ADMA reported negative operating cash flow during the last 5 years.
1.2 Ratios
ADMA has a better Return On Assets (37.42%) than 98.89% of its industry peers.
ADMA has a better Return On Equity (52.45%) than 98.89% of its industry peers.
With an excellent Return On Invested Capital value of 25.43%, ADMA belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 37.42% | ||
| ROE | 52.45% | ||
| ROIC | 25.43% |
ROA(3y)4.32%
ROA(5y)-9.88%
ROE(3y)-2.53%
ROE(5y)-28.83%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 44.06%, ADMA belongs to the best of the industry, outperforming 98.52% of the companies in the same industry.
ADMA has a Operating Margin of 32.82%. This is amongst the best in the industry. ADMA outperforms 97.41% of its industry peers.
ADMA's Gross Margin of 53.00% is fine compared to the rest of the industry. ADMA outperforms 75.74% of its industry peers.
In the last couple of years the Gross Margin of ADMA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.82% | ||
| PM (TTM) | 44.06% | ||
| GM | 53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y226.2%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ADMA is creating value.
The number of shares outstanding for ADMA has been increased compared to 1 year ago.
ADMA has more shares outstanding than it did 5 years ago.
ADMA has a better debt/assets ratio than last year.
2.2 Solvency
ADMA has an Altman-Z score of 15.53. This indicates that ADMA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ADMA (15.53) is better than 89.63% of its industry peers.
ADMA has a debt to FCF ratio of 1.12. This is a very positive value and a sign of high solvency as it would only need 1.12 years to pay back of all of its debts.
ADMA has a Debt to FCF ratio of 1.12. This is amongst the best in the industry. ADMA outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ADMA is not too dependend on debt financing.
The Debt to Equity ratio of ADMA (0.18) is worse than 68.33% of its industry peers.
Even though the debt/equity ratio score it not favorable for ADMA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.12 | ||
| Altman-Z | 15.53 |
ROIC/WACC2.63
WACC9.67%
2.3 Liquidity
ADMA has a Current Ratio of 5.33. This indicates that ADMA is financially healthy and has no problem in meeting its short term obligations.
ADMA has a Current ratio (5.33) which is comparable to the rest of the industry.
A Quick Ratio of 2.78 indicates that ADMA has no problem at all paying its short term obligations.
ADMA's Quick ratio of 2.78 is on the low side compared to the rest of the industry. ADMA is outperformed by 64.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.33 | ||
| Quick Ratio | 2.78 |
3. Growth
3.1 Past
ADMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 285.71%, which is quite impressive.
The Revenue has grown by 43.58% in the past year. This is a very strong growth!
ADMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 70.84% yearly.
EPS 1Y (TTM)285.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.69%
Revenue 1Y (TTM)43.58%
Revenue growth 3Y74.04%
Revenue growth 5Y70.84%
Sales Q2Q%13.8%
3.2 Future
The Earnings Per Share is expected to grow by 32.01% on average over the next years. This is a very strong growth
ADMA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.46% yearly.
EPS Next Y16.79%
EPS Next 2Y35.87%
EPS Next 3Y35.8%
EPS Next 5Y32.01%
Revenue Next Year19.81%
Revenue Next 2Y22.86%
Revenue Next 3Y24.46%
Revenue Next 5Y22.46%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
ADMA is valuated quite expensively with a Price/Earnings ratio of 28.51.
Based on the Price/Earnings ratio, ADMA is valued cheaper than 92.78% of the companies in the same industry.
When comparing the Price/Earnings ratio of ADMA to the average of the S&P500 Index (27.27), we can say ADMA is valued inline with the index average.
With a Price/Forward Earnings ratio of 16.68, ADMA is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ADMA indicates a rather cheap valuation: ADMA is cheaper than 93.70% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. ADMA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.51 | ||
| Fwd PE | 16.68 |
4.2 Price Multiples
ADMA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ADMA is cheaper than 93.15% of the companies in the same industry.
ADMA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ADMA is cheaper than 92.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.99 | ||
| EV/EBITDA | 22.22 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ADMA has a very decent profitability rating, which may justify a higher PE ratio.
ADMA's earnings are expected to grow with 35.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y35.87%
EPS Next 3Y35.8%
5. Dividend
5.1 Amount
ADMA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ADMA (9/16/2025, 12:05:07 PM)
15.395
+0.09 (+0.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners90.24%
Inst Owner Change1%
Ins Owners2.35%
Ins Owner Change-1.04%
Market Cap3.67B
Analysts82
Price Target29.64 (92.53%)
Short Float %6.54%
Short Ratio4.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.56%
Min EPS beat(2)-31.17%
Max EPS beat(2)-1.96%
EPS beat(4)1
Avg EPS beat(4)-7.13%
Min EPS beat(4)-31.17%
Max EPS beat(4)13.12%
EPS beat(8)4
Avg EPS beat(8)-13.7%
EPS beat(12)6
Avg EPS beat(12)-7.65%
EPS beat(16)9
Avg EPS beat(16)-4.75%
Revenue beat(2)0
Avg Revenue beat(2)-2.91%
Min Revenue beat(2)-3.31%
Max Revenue beat(2)-2.51%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-3.31%
Max Revenue beat(4)10.99%
Revenue beat(8)6
Avg Revenue beat(8)4.93%
Revenue beat(12)10
Avg Revenue beat(12)6.13%
Revenue beat(16)14
Avg Revenue beat(16)6.66%
PT rev (1m)0%
PT rev (3m)-1.46%
EPS NQ rev (1m)-8%
EPS NQ rev (3m)-14.82%
EPS NY rev (1m)-5.63%
EPS NY rev (3m)-13.26%
Revenue NQ rev (1m)0.68%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.51 | ||
| Fwd PE | 16.68 | ||
| P/S | 7.75 | ||
| P/FCF | 55.99 | ||
| P/OCF | 47.89 | ||
| P/B | 9.22 | ||
| P/tB | 9.32 | ||
| EV/EBITDA | 22.22 |
EPS(TTM)0.54
EY3.51%
EPS(NY)0.92
Fwd EY6%
FCF(TTM)0.27
FCFY1.79%
OCF(TTM)0.32
OCFY2.09%
SpS1.99
BVpS1.67
TBVpS1.65
PEG (NY)1.7
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 37.42% | ||
| ROE | 52.45% | ||
| ROCE | 32.19% | ||
| ROIC | 25.43% | ||
| ROICexc | 31.27% | ||
| ROICexgc | 31.6% | ||
| OM | 32.82% | ||
| PM (TTM) | 44.06% | ||
| GM | 53% | ||
| FCFM | 13.84% |
ROA(3y)4.32%
ROA(5y)-9.88%
ROE(3y)-2.53%
ROE(5y)-28.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y226.2%
GM growth 5YN/A
F-Score5
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.12 | ||
| Debt/EBITDA | 0.45 | ||
| Cap/Depr | 140.25% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 13.21 | ||
| Cash Conversion | 46.9% | ||
| Profit Quality | 31.4% | ||
| Current Ratio | 5.33 | ||
| Quick Ratio | 2.78 | ||
| Altman-Z | 15.53 |
F-Score5
WACC9.67%
ROIC/WACC2.63
Cap/Depr(3y)120.67%
Cap/Depr(5y)186.15%
Cap/Sales(3y)4.32%
Cap/Sales(5y)11.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)285.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.69%
EPS Next Y16.79%
EPS Next 2Y35.87%
EPS Next 3Y35.8%
EPS Next 5Y32.01%
Revenue 1Y (TTM)43.58%
Revenue growth 3Y74.04%
Revenue growth 5Y70.84%
Sales Q2Q%13.8%
Revenue Next Year19.81%
Revenue Next 2Y22.86%
Revenue Next 3Y24.46%
Revenue Next 5Y22.46%
EBIT growth 1Y85.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.39%
EBIT Next 3Y41.12%
EBIT Next 5Y36.1%
FCF growth 1Y227.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.06%
OCF growth 3YN/A
OCF growth 5YN/A